Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 06, 2007 Filed Nov 8, 2007 21:52 UTC |
DORMAN DAVID WDirector
|
GrantShare Credits · Derivative | 23.912 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000165 · doc.xml · derivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,187.2866 Underlying: Common Stock · 23.912 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| November 06, 2007 Filed Nov 8, 2007 21:53 UTC |
HEARD MARIAN LDirector
|
GrantShare Credits · Derivative | 23.912 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000166 · doc.xml · derivative · entry 1 HEARD MARIAN L · CIK 0001198220 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,719.1808 Underlying: Common Stock · 23.912 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| November 06, 2007 Filed Nov 8, 2007 21:53 UTC |
JOYCE WILLIAM HDirector
|
GrantShare Credits · Derivative | 23.912 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000167 · doc.xml · derivative · entry 1 JOYCE WILLIAM H · CIK 0001009124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,911.8817 Underlying: Common Stock · 23.912 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| November 06, 2007 Filed Nov 8, 2007 21:53 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 23 | $41.82 | $961.86 |
DisclosureSEC source: 0000064803-07-000168 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,789 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| November 06, 2007 Filed Nov 8, 2007 21:54 UTC |
ROSENBERG SHELI ZDirector
|
GrantCommon Stock | 23 | $41.82 | $961.86 |
DisclosureSEC source: 0000064803-07-000171 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,454.6225 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| November 06, 2007 Filed Nov 8, 2007 21:55 UTC |
RYAN THOMAS MDirector · CEO & President
|
GiftCommon Stock | 24,350 | $41.82 | $1,018,317.00 |
DisclosureSEC source: 0000064803-07-000174 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,093 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| November 06, 2007 Filed Nov 15, 2007 21:30 UTC Amendment |
BROWN C DAVID IIDirector
|
GrantCommon Stock | 23 | $41.82 | $961.86 |
DisclosureSEC source: 0000064803-07-000179 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| November 06, 2007 Filed Feb 4, 2008 21:33 UTC Amendment |
RYAN THOMAS MDirector · CEO & President
|
GiftCommon Stock | 12,200 | $41.35 | $504,470.00 |
DisclosureSEC source: 0000064803-08-000013 · doc.xml · nonDerivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Foundation Disclosed balance after: 37,000 Read SEC document |
| November 06, 2007 Filed Feb 4, 2008 21:33 UTC Amendment |
RYAN THOMAS MDirector · CEO & President
|
GiftCommon Stock | 24,350 | $41.82 | $1,018,317.00 |
DisclosureSEC source: 0000064803-08-000013 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,093 F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| November 05, 2007 Filed Nov 8, 2007 21:55 UTC |
RYAN THOMAS MDirector · CEO & President
|
GiftCommon Stock | 17,030 | $41.35 | $704,190.50 |
DisclosureSEC source: 0000064803-07-000174 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,443 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| November 05, 2007 Filed Feb 4, 2008 21:33 UTC Amendment |
RYAN THOMAS MDirector · CEO & President
|
GiftCommon Stock | 17,030 | $41.35 | $704,190.50 |
DisclosureSEC source: 0000064803-08-000013 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,443 F1 · shares: Of the shares gifted by the reporting person on November 5, 2007, 12,200 shares were gifted to a family foundation. The reporting person disclaims beneficial ownership of these shares. F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| October 30, 2007 Filed Oct 31, 2007 19:55 UTC |
HEARD MARIAN LDirector
|
GrantShare Credits · Derivative | 24 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000159 · doc.xml · derivative · entry 2 HEARD MARIAN L · CIK 0001198220 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,554 Underlying: Common Stock · 24 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| October 30, 2007 Filed Oct 31, 2007 19:56 UTC |
JOYCE WILLIAM HDirector
|
GrantShare Credits · Derivative | 24 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000160 · doc.xml · derivative · entry 2 JOYCE WILLIAM H · CIK 0001009124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,688 Underlying: Common Stock · 24 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:55 UTC |
DORMAN DAVID WDirector
|
GrantShare Credits · Derivative | 23 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000158 · doc.xml · derivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,136 Underlying: Common Stock · 23 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:55 UTC |
BROWN C DAVID IIDirector
|
GrantCommon Stock | 23 | $41.83 | $962.09 |
DisclosureSEC source: 0000064803-07-000156 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:55 UTC |
HEARD MARIAN LDirector
|
GrantShare Credits · Derivative | 23 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000159 · doc.xml · derivative · entry 1 HEARD MARIAN L · CIK 0001198220 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,530 Underlying: Common Stock · 23 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:55 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
GrantCommon Stock | 23 | $41.83 | $962.09 |
DisclosureSEC source: 0000064803-07-000157 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,572 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:56 UTC |
JOYCE WILLIAM HDirector
|
GrantShare Credits · Derivative | 23 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000160 · doc.xml · derivative · entry 1 JOYCE WILLIAM H · CIK 0001009124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,664 Underlying: Common Stock · 23 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:56 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 23 | $41.83 | $962.09 |
DisclosureSEC source: 0000064803-07-000161 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,766 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| October 29, 2007 Filed Oct 31, 2007 19:56 UTC |
ROSENBERG SHELI ZDirector
|
GrantCommon Stock | 23 | $41.83 | $962.09 |
DisclosureSEC source: 0000064803-07-000162 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,136 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:20 UTC |
BROWN C DAVID IIDirector
|
GrantCommon Stock | 76 | $39.19 | $2,978.44 |
DisclosureSEC source: 0000064803-07-000149 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:21 UTC |
DORMAN DAVID WDirector
|
GrantShare Credits · Derivative | 77 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000151 · doc.xml · derivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,113 Underlying: Common Stock · 77 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:20 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
GrantCommon Stock | 51 | $39.19 | $1,998.69 |
DisclosureSEC source: 0000064803-07-000150 · doc.xml · nonDerivative · entry 1 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,549 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:21 UTC |
HEARD MARIAN LDirector
|
GrantShare Credits · Derivative | 51 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000152 · doc.xml · derivative · entry 2 HEARD MARIAN L · CIK 0001198220 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,507 Underlying: Common Stock · 51 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:21 UTC |
JOYCE WILLIAM HDirector
|
GrantShare Credits · Derivative | 51 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000153 · doc.xml · derivative · entry 2 JOYCE WILLIAM H · CIK 0001009124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,641 Underlying: Common Stock · 51 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:21 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 76 | $39.19 | $2,978.44 |
DisclosureSEC source: 0000064803-07-000154 · doc.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,743 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. Read SEC document |
| September 26, 2007 Filed Sep 27, 2007 20:21 UTC |
ROSENBERG SHELI ZDirector
|
GrantCommon Stock | 76 | $39.19 | $2,978.44 |
DisclosureSEC source: 0000064803-07-000155 · doc.xml · nonDerivative · entry 1 ROSENBERG SHELI Z · CIK 0001198222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,113 F1 · shares: Consists of common stock acquired as annual grant, semi-annual compensation and/or meeting fees pursuant to the issuer's 1997 Incentive Compensation Plan. F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| September 25, 2007 Filed Sep 27, 2007 20:21 UTC |
HEARD MARIAN LDirector
|
GrantShare Credits · Derivative | 26 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000152 · doc.xml · derivative · entry 1 HEARD MARIAN L · CIK 0001198220 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,456 Underlying: Common Stock · 26 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| September 25, 2007 Filed Sep 27, 2007 20:21 UTC |
JOYCE WILLIAM HDirector
|
GrantShare Credits · Derivative | 26 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000153 · doc.xml · derivative · entry 1 JOYCE WILLIAM H · CIK 0001009124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,590 Underlying: Common Stock · 26 shares Expires not disclosed F1 · shares: Consists of share credits acquired as deferred annual grant, semi-annual compensation and/or meeting fees all at market price pursuant to the 1997 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| September 04, 2007 Filed Sep 4, 2007 21:15 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
Exercise / conversionStock Option · Derivative | 400,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0000064803-07-000147 · doc.xml · derivative · entry 11 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,594,611 Underlying: Common Stock · 400,000 shares Expires 2010-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| September 04, 2007 Filed Sep 4, 2007 21:15 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
SaleCommon Stock | 400,000 | $38.16 | $15,264,040.00 |
DisclosureSEC source: 0000064803-07-000147 · doc.xml · nonDerivative · entry 4 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,498 Read SEC document |
| September 04, 2007 Filed Sep 4, 2007 21:15 UTC |
CRAWFORD EDWIN MDirector · Chairman
|
Exercise / conversionCommon Stock | 400,000 | $2.37 | $948,000.00 |
DisclosureSEC source: 0000064803-07-000147 · doc.xml · nonDerivative · entry 3 CRAWFORD EDWIN M · CIK 0001197677 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · derivative · entry 12 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · derivative · entry 11 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionStock Option · Derivative | 46,856 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · derivative · entry 10 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,856 shares Expires 2014-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionStock Option · Derivative | 10,679 | $0.00 Strike: $9.17 | $0.00 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · derivative · entry 9 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,170 Underlying: Common Stock · 10,679 shares Expires 2013-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC |
BROWN C DAVID IIDirector
|
SaleCommon Stock | 125,000 | $37.75 | $4,718,762.50 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 6 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC |
BROWN C DAVID IIDirector
|
SaleCommon Stock | 38,751 | $37.75 | $1,462,850.25 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 5 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionCommon Stock | 33,726 | $27.12 | $914,649.12 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 4 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionCommon Stock | 33,739 | $20.23 | $682,539.97 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 3 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionCommon Stock | 46,856 | $13.41 | $628,338.96 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:12 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionCommon Stock | 10,679 | $9.17 | $97,926.43 |
DisclosureSEC source: 0000064803-07-000144 · doc.xml · nonDerivative · entry 1 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionStock Option · Derivative | 33,726 | $0.00 Strike: $27.12 | $0.00 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · derivative · entry 12 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,726 shares Expires 2016-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionStock Option · Derivative | 33,739 | $0.00 Strike: $20.23 | $0.00 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · derivative · entry 11 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,739 shares Expires 2015-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionStock Option · Derivative | 46,856 | $0.00 Strike: $13.41 | $0.00 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · derivative · entry 10 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,856 shares Expires 2014-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionStock Option · Derivative | 10,679 | $0.00 Strike: $9.17 | $0.00 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · derivative · entry 9 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,170 Underlying: Common Stock · 10,679 shares Expires 2013-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC |
BROWN C DAVID IIDirector
|
SaleCommon Stock | 125,000 | $37.75 | $4,718,762.50 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · nonDerivative · entry 6 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC |
BROWN C DAVID IIDirector
|
SaleCommon Stock | 38,751 | $37.75 | $1,462,850.25 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · nonDerivative · entry 5 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionCommon Stock | 33,726 | $27.12 | $914,649.12 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · nonDerivative · entry 4 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| August 31, 2007 Filed Sep 4, 2007 21:14 UTC |
BROWN C DAVID IIDirector
|
Exercise / conversionCommon Stock | 33,739 | $20.23 | $682,539.97 |
DisclosureSEC source: 0000064803-07-000146 · doc.xml · nonDerivative · entry 3 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.